KGI Securities has initiated InnoTek at “outperform” with a target price of 73 cents based on the company’s 0.5x EV/EBITDA, a slight discount to its fellow SGX-listed manufacturing service companies.

KGI analyst Kenny Tan believe that the company will enjoy a stable outlook that is supported by demand from China for its automotive business. The company is also expected to see its business recover to its pre-pandemic levels.

SEE: Acquisitions positive for Q&M Dental Group, core business still resilient: KGI Securities

InnoTek’s restructuring efforts that were conducted in 2014/2015 were deemed successful as the current management team now has a five-year record for making profit and generating free cashflow.

“InnoTek possesses a strong balance sheet with the ability to generate free cash flow and maintain current dividend rates,” says Tan.

Apart from the restructuring, InnoTek was also able to manoeuvre around a weak Covid-19 induced 1QFY2020 performance and produced resilient 2QFY2020 results that saw y-o-y growth.

For more stories about where the money flows, click here for our Capital section

The company’s diversified customer base, which contributes to its stable outlook, is yet another positive.

On this, Tan expects revenues to rebound in FY2021, although it may stay below the $200 million mark unless the company announces new projects in its pipeline.

“We forecast FY20/21/22F PATMI at -39%/+25%/+2.5% y-o-y, while FY20/21/22F EBITDA is +1.4%/+8.8%/-0.1% y-o-y as right-of-use depreciation and interest expenses climb,” he adds.

Shares in InnoTek closed 2 cents higher or 3.1% up at 67 cents on Jan 13.